Indonesia Now
BPOM Officially Approves Inavolisib for Breast Cancer Treatment
The Indonesian Food and Drug Authority (BPOM) has approved inavolisib to treat HR-positive, HER2-negative breast cancer with PIK3CA mutations.
Rabu, 11 Nov 2026 14:00 WIB







































